Effects of Weight Loss in Obese Difficult-to-treat Asthmatics
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01047657|
Recruitment Status : Completed
First Posted : January 13, 2010
Last Update Posted : February 23, 2011
|Condition or disease||Intervention/treatment||Phase|
|Asthma Obesity Weight Loss||Behavioral: Low caloric diet plus orlistat and sibutramine||Phase 3|
Study design: interventional, open label, randomized
Thirty-three difficult to control obese asthmatic patients, aged between 18 to 65 years old will be recruited from the outpatient clinics of the Pulmonary Division of the University of Sao Paulo Hospital.
Difficult to control asthma will be defined as patients who do not achieve asthma control (according to GINA) despite best treatment regimen and checked adherence after at least three months of treatment.
Intervention: Patients will be divided in two groups: asthma treatment plus weight loss program or asthma treatment alone for 6 months without drug dose changing.
Procedures (baseline and after 6 months) - quality of life questionnaire, asthma control questionnaire, lung function tests, serum and sputum inflammatory markers.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||33 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Effects of Weight Loss in Obese Difficult-to-treat Asthmatics: a Pilot Study|
|Study Start Date :||November 2009|
|Actual Primary Completion Date :||December 2010|
|Actual Study Completion Date :||December 2010|
|Experimental: weight loss||
Behavioral: Low caloric diet plus orlistat and sibutramine
|No Intervention: Control|
- Asthma control questionnaire (ACQ) [ Time Frame: Baseline and six months ]
- Inflammatory parameters [ Time Frame: Baseline and after 6 months ]
- Pulmonary mechanics [ Time Frame: Baseline and after 6 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01047657
|University of São Paulo - Heart Institute and Hospital das Clínicas|
|São Paulo, Brazil, 05403-904|
|Principal Investigator:||Sérvulo A. Dias-Júnior, MD||Heart Institute - University of São Paulo|
|Study Director:||Alberto Cukier, PhD||Heart Institute - University of São Paulo|